nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0148	0.0507	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0107	0.0366	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00875	0.0299	CcSEcCtD
Pentosan Polysulfate—Gastritis—Spironolactone—dilated cardiomyopathy	0.00837	0.0286	CcSEcCtD
Pentosan Polysulfate—FGF1—cardiac ventricle—dilated cardiomyopathy	0.00712	0.247	CbGeAlD
Pentosan Polysulfate—FGF1—myocardium—dilated cardiomyopathy	0.00669	0.233	CbGeAlD
Pentosan Polysulfate—FGF2—heart—dilated cardiomyopathy	0.00628	0.218	CbGeAlD
Pentosan Polysulfate—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00586	0.0201	CcSEcCtD
Pentosan Polysulfate—Alopecia—Spironolactone—dilated cardiomyopathy	0.00578	0.0198	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00529	0.0181	CcSEcCtD
Pentosan Polysulfate—Malaise—Spironolactone—dilated cardiomyopathy	0.00514	0.0176	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0051	0.0174	CcSEcCtD
Pentosan Polysulfate—Discomfort—Spironolactone—dilated cardiomyopathy	0.00479	0.0164	CcSEcCtD
Pentosan Polysulfate—Dehydration—Furosemide—dilated cardiomyopathy	0.00479	0.0164	CcSEcCtD
Pentosan Polysulfate—FGF1—heart—dilated cardiomyopathy	0.00467	0.162	CbGeAlD
Pentosan Polysulfate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00455	0.0156	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0044	0.015	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00411	0.0141	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00406	0.0139	CcSEcCtD
Pentosan Polysulfate—FGF1—cardiac atrium—dilated cardiomyopathy	0.004	0.139	CbGeAlD
Pentosan Polysulfate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00383	0.0131	CcSEcCtD
Pentosan Polysulfate—Sweating—Furosemide—dilated cardiomyopathy	0.0038	0.013	CcSEcCtD
Pentosan Polysulfate—Urticaria—Spironolactone—dilated cardiomyopathy	0.00369	0.0126	CcSEcCtD
Pentosan Polysulfate—Dehydration—Lisinopril—dilated cardiomyopathy	0.00359	0.0123	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00343	0.0117	CcSEcCtD
Pentosan Polysulfate—Gastritis—Lisinopril—dilated cardiomyopathy	0.00342	0.0117	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Furosemide—dilated cardiomyopathy	0.00332	0.0114	CcSEcCtD
Pentosan Polysulfate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00329	0.0113	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00325	0.0111	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00325	0.0111	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00318	0.0109	CcSEcCtD
Pentosan Polysulfate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00308	0.0105	CcSEcCtD
Pentosan Polysulfate—Flatulence—Furosemide—dilated cardiomyopathy	0.00305	0.0104	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00305	0.0104	CcSEcCtD
Pentosan Polysulfate—Weight increased—Lisinopril—dilated cardiomyopathy	0.00304	0.0104	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00302	0.0103	CcSEcCtD
Pentosan Polysulfate—Depression—Lisinopril—dilated cardiomyopathy	0.00297	0.0102	CcSEcCtD
Pentosan Polysulfate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00296	0.0101	CcSEcCtD
Pentosan Polysulfate—Rash—Spironolactone—dilated cardiomyopathy	0.00293	0.01	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00293	0.01	CcSEcCtD
Pentosan Polysulfate—Headache—Spironolactone—dilated cardiomyopathy	0.00291	0.00997	CcSEcCtD
Pentosan Polysulfate—Jaundice—Lisinopril—dilated cardiomyopathy	0.0029	0.00992	CcSEcCtD
Pentosan Polysulfate—Anaemia—Furosemide—dilated cardiomyopathy	0.00287	0.0098	CcSEcCtD
Pentosan Polysulfate—Sweating—Lisinopril—dilated cardiomyopathy	0.00285	0.00976	CcSEcCtD
Pentosan Polysulfate—Agitation—Furosemide—dilated cardiomyopathy	0.00285	0.00975	CcSEcCtD
Pentosan Polysulfate—Haematuria—Lisinopril—dilated cardiomyopathy	0.00284	0.00971	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00281	0.0096	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00279	0.00955	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Furosemide—dilated cardiomyopathy	0.00278	0.00949	CcSEcCtD
Pentosan Polysulfate—Nausea—Spironolactone—dilated cardiomyopathy	0.00276	0.00945	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00268	0.00916	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00265	0.00907	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00249	0.00852	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00248	0.00847	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00245	0.00837	CcSEcCtD
Pentosan Polysulfate—Anorexia—Furosemide—dilated cardiomyopathy	0.00241	0.00825	CcSEcCtD
Pentosan Polysulfate—Alopecia—Lisinopril—dilated cardiomyopathy	0.00236	0.00808	CcSEcCtD
Pentosan Polysulfate—Flatulence—Lisinopril—dilated cardiomyopathy	0.00229	0.00784	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00227	0.00777	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0022	0.00752	CcSEcCtD
Pentosan Polysulfate—Constipation—Furosemide—dilated cardiomyopathy	0.00216	0.0074	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00216	0.00738	CcSEcCtD
Pentosan Polysulfate—Anaemia—Lisinopril—dilated cardiomyopathy	0.00215	0.00735	CcSEcCtD
Pentosan Polysulfate—Malaise—Lisinopril—dilated cardiomyopathy	0.0021	0.00718	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00209	0.00713	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00208	0.00712	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00207	0.00708	CcSEcCtD
Pentosan Polysulfate—Urticaria—Furosemide—dilated cardiomyopathy	0.00201	0.00688	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.002	0.00684	CcSEcCtD
Pentosan Polysulfate—Myalgia—Lisinopril—dilated cardiomyopathy	0.00198	0.00677	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00198	0.00677	CcSEcCtD
Pentosan Polysulfate—Discomfort—Lisinopril—dilated cardiomyopathy	0.00196	0.00669	CcSEcCtD
Pentosan Polysulfate—Oedema—Lisinopril—dilated cardiomyopathy	0.0019	0.00649	CcSEcCtD
Pentosan Polysulfate—Infection—Lisinopril—dilated cardiomyopathy	0.00189	0.00645	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00186	0.00638	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00186	0.00636	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00184	0.00628	CcSEcCtD
Pentosan Polysulfate—Anorexia—Lisinopril—dilated cardiomyopathy	0.00181	0.00619	CcSEcCtD
Pentosan Polysulfate—Pruritus—Furosemide—dilated cardiomyopathy	0.00179	0.00612	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00173	0.00592	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00173	0.00592	CcSEcCtD
Pentosan Polysulfate—Insomnia—Lisinopril—dilated cardiomyopathy	0.00172	0.00587	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.0017	0.00583	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00169	0.00579	CcSEcCtD
Pentosan Polysulfate—Dizziness—Furosemide—dilated cardiomyopathy	0.00167	0.00572	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00167	0.00572	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00165	0.00565	CcSEcCtD
Pentosan Polysulfate—Constipation—Lisinopril—dilated cardiomyopathy	0.00162	0.00555	CcSEcCtD
Pentosan Polysulfate—Vomiting—Furosemide—dilated cardiomyopathy	0.00161	0.0055	CcSEcCtD
Pentosan Polysulfate—Rash—Furosemide—dilated cardiomyopathy	0.0016	0.00546	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00159	0.00545	CcSEcCtD
Pentosan Polysulfate—Headache—Furosemide—dilated cardiomyopathy	0.00159	0.00542	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00156	0.00535	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00155	0.00531	CcSEcCtD
Pentosan Polysulfate—FGF4—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.00154	0.00228	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.00154	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IGF1R signaling cascade—RAF1—dilated cardiomyopathy	0.00154	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Insulin receptor signalling cascade—RAF1—dilated cardiomyopathy	0.00154	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.00154	0.00226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.00153	0.00226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—RAF1—dilated cardiomyopathy	0.00153	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.00151	0.00223	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00151	0.00516	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.00151	0.00222	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Furosemide—dilated cardiomyopathy	0.0015	0.00514	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0015	0.00513	CcSEcCtD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.0015	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.0015	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-mediated signalling—RAF1—dilated cardiomyopathy	0.0015	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.00149	0.0022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—RAC1—dilated cardiomyopathy	0.00148	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—RAC1—dilated cardiomyopathy	0.00146	0.00216	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events—RAF1—dilated cardiomyopathy	0.00146	0.00214	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events triggered by IGF1R—RAF1—dilated cardiomyopathy	0.00144	0.00213	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00144	0.00212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.00144	0.00212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.00144	0.00212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—RAF1—dilated cardiomyopathy	0.00144	0.00212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.00143	0.0021	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00141	0.00208	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.00141	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—RAF1—dilated cardiomyopathy	0.00141	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Insulin receptor signalling cascade—RAF1—dilated cardiomyopathy	0.00141	0.00207	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0014	0.00478	CcSEcCtD
Pentosan Polysulfate—FGF2—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.00138	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—RAC1—dilated cardiomyopathy	0.00138	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.00138	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00137	0.00202	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00134	0.00459	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—RAC1—dilated cardiomyopathy	0.00133	0.00197	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00132	0.00195	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0013	0.00444	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.0013	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—RAF1—dilated cardiomyopathy	0.00128	0.00189	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.00127	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—RAC1—dilated cardiomyopathy	0.00126	0.00185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.00126	0.00185	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00126	0.00429	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00125	0.00184	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00121	0.00413	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.0012	0.00177	CbGpPWpGaD
Pentosan Polysulfate—Rash—Lisinopril—dilated cardiomyopathy	0.0012	0.00409	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0012	0.00409	CcSEcCtD
Pentosan Polysulfate—Headache—Lisinopril—dilated cardiomyopathy	0.00119	0.00407	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.00118	0.00174	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00118	0.00174	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—RAF1—dilated cardiomyopathy	0.00117	0.00172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00113	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00113	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.00113	0.00167	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Lisinopril—dilated cardiomyopathy	0.00113	0.00386	CcSEcCtD
Pentosan Polysulfate—FGF1—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.00112	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.00111	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PSEN2—dilated cardiomyopathy	0.0011	0.00162	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.0011	0.00161	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.00106	0.00157	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.00106	0.00156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.00105	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—EGFR—dilated cardiomyopathy	0.00105	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00105	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.00105	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.00103	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.00103	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.00103	0.00151	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.00102	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.00101	0.00148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI-3K cascade—EGFR—dilated cardiomyopathy	0.001	0.00148	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000999	0.00147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000987	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000986	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000986	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000986	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000985	0.00145	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.000981	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.00098	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—RAF1—dilated cardiomyopathy	0.00098	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000979	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000977	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000975	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000973	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—RAF1—dilated cardiomyopathy	0.00097	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000969	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000965	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.000955	0.00141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000955	0.00141	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.000951	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.00094	0.00139	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000938	0.00138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NPPA—dilated cardiomyopathy	0.000931	0.00137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI-3K cascade—EGFR—dilated cardiomyopathy	0.000916	0.00135	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000913	0.00134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000913	0.00134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000913	0.00134	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—EGFR—dilated cardiomyopathy	0.000913	0.00134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000905	0.00133	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PSEN2—dilated cardiomyopathy	0.000901	0.00133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000898	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000897	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CD36—dilated cardiomyopathy	0.000894	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.000894	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.000894	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000893	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000889	0.00131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000887	0.00131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—RAF1—dilated cardiomyopathy	0.000885	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000874	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.000867	0.00128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000859	0.00127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000859	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000855	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—RAC1—dilated cardiomyopathy	0.000843	0.00124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000832	0.00123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000832	0.00123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000832	0.00123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000825	0.00122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000818	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000814	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000809	0.00119	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000809	0.00119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000783	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000751	0.00111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000737	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000719	0.00106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000719	0.00106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000707	0.00104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000687	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000685	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000675	0.000995	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000672	0.00099	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000672	0.00099	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000669	0.000985	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000665	0.00098	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000656	0.000966	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000655	0.000965	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000655	0.000965	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000645	0.00095	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000639	0.000941	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000631	0.00093	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000626	0.000922	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000626	0.000922	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000626	0.000922	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000622	0.000916	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.00062	0.000914	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000616	0.000907	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000615	0.000906	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000613	0.000903	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000612	0.000902	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ITGB1—dilated cardiomyopathy	0.000611	0.000899	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.00061	0.000898	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000607	0.000894	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000598	0.000881	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NPPA—dilated cardiomyopathy	0.000591	0.00087	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000589	0.000868	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CD36—dilated cardiomyopathy	0.000586	0.000863	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000583	0.000858	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—EGFR—dilated cardiomyopathy	0.000579	0.000853	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PSEN2—dilated cardiomyopathy	0.000572	0.000843	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000571	0.000841	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000571	0.000841	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000571	0.000841	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CD36—dilated cardiomyopathy	0.000568	0.000836	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000567	0.000835	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000566	0.000833	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000561	0.000826	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000561	0.000826	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00056	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00056	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—RAF1—dilated cardiomyopathy	0.000559	0.000823	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000558	0.000822	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000554	0.000817	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—RAC1—dilated cardiomyopathy	0.000552	0.000814	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000545	0.000803	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NPPA—dilated cardiomyopathy	0.000539	0.000793	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000537	0.000791	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000537	0.00079	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—RAC1—dilated cardiomyopathy	0.000535	0.000788	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—EGFR—dilated cardiomyopathy	0.000528	0.000778	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PSEN2—dilated cardiomyopathy	0.000522	0.000768	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000521	0.000767	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD36—dilated cardiomyopathy	0.000521	0.000767	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CD36—dilated cardiomyopathy	0.000518	0.000762	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000514	0.000757	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000512	0.000754	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000506	0.000745	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000505	0.000743	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000497	0.000732	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—RAC1—dilated cardiomyopathy	0.000491	0.000723	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—RAC1—dilated cardiomyopathy	0.000488	0.000719	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000468	0.00069	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—RAC1—dilated cardiomyopathy	0.000453	0.000668	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000431	0.000635	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000426	0.000628	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000409	0.000602	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000401	0.00059	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000389	0.000573	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ITGB1—dilated cardiomyopathy	0.000388	0.000571	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—dilated cardiomyopathy	0.000383	0.000564	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000368	0.000542	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—RAF1—dilated cardiomyopathy	0.000366	0.000539	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000365	0.000538	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000356	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000356	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—RAF1—dilated cardiomyopathy	0.000355	0.000522	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ITGB1—dilated cardiomyopathy	0.000353	0.000521	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000351	0.000517	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000341	0.000502	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000331	0.000487	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD36—dilated cardiomyopathy	0.000331	0.000487	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—RAF1—dilated cardiomyopathy	0.000325	0.000479	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000324	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000324	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—RAF1—dilated cardiomyopathy	0.000323	0.000476	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00032	0.000472	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000317	0.000467	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAC1—dilated cardiomyopathy	0.000312	0.000459	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000311	0.000458	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGT—dilated cardiomyopathy	0.000303	0.000447	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000302	0.000444	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD36—dilated cardiomyopathy	0.000302	0.000444	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—RAF1—dilated cardiomyopathy	0.000301	0.000443	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000292	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAC1—dilated cardiomyopathy	0.000288	0.000424	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAC1—dilated cardiomyopathy	0.000284	0.000419	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000274	0.000403	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAC1—dilated cardiomyopathy	0.000262	0.000386	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000259	0.000382	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—dilated cardiomyopathy	0.000251	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000249	0.000367	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—dilated cardiomyopathy	0.000243	0.000358	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—dilated cardiomyopathy	0.000239	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000237	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000234	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—dilated cardiomyopathy	0.000223	0.000329	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000223	0.000328	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—dilated cardiomyopathy	0.000222	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000213	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00021	0.00031	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAF1—dilated cardiomyopathy	0.000207	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—dilated cardiomyopathy	0.000206	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000203	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000201	0.000297	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000192	0.000283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—dilated cardiomyopathy	0.000191	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—dilated cardiomyopathy	0.000188	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000184	0.000271	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000176	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—dilated cardiomyopathy	0.000174	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000144	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—dilated cardiomyopathy	0.000142	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000134	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—dilated cardiomyopathy	0.000131	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—dilated cardiomyopathy	0.000129	0.00019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000122	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—dilated cardiomyopathy	0.000119	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.16e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—dilated cardiomyopathy	8.35e-05	0.000123	CbGpPWpGaD
